MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$6,610K
EPS
-$1.68
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
Research and development
2,825
3,661
General and administrative
4,049
3,630
Total operating expenses
6,874
7,291
Loss from operations
-6,874
-7,291
Other income, net
263
325
Net loss
-6,611
-6,966
Unrealized (loss) gain on available-for-sale securities
1
1
Comprehensive loss attributable to common stockholders
-6,610
-6,965
Basic EPS
-1.68
-0.18
Diluted EPS
-1.68
-0.18
Basic Average Shares
3,943,887
39,092,961
Diluted Average Shares
3,943,887
39,092,961
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
attributable to common...
-$6,610K
Unrealized (loss) gain on
available-for-sale securities
$1K
Net loss
-$6,611K
Other income, net
$263K
Loss from operations
-$6,874K
Total operating
expenses
$6,874K
General and
administrative
$4,049K
Research and development
$2,825K
Buy us a coffee
Athira Pharma, Inc. (ATHA)
Athira Pharma, Inc. (ATHA)